Titlebook: Biomarkers in Cardiovascular Disease; Vinood B. Patel,Victor R. Preedy Reference work 2016 Springer Science+Business Media Dordrecht 2016

斜谷

巫婆

Uncarboxylated Matrix Gla Protein as a Biomarker in Cardiovascular Disease: Applications for Researche formation of inactive MGP, also known as uncarboxylated MGP, which is set free in the blood stream where it is available for quantification by ELISA-based assays. In the healthy adult population, significant concentrations of uncarboxylated MGP are found, suggesting a widespread dietary vitamin K

MEEK

MicroRNA-133: Biomarker and Mediator of Cardiovascular Diseasesar as recently discovered and structurally small pieces of genetic material, but we should make no mistake to underestimate these modest but powerful molecules. Regulating no less than half of the transcriptome, their influence is a key for the fine-tuning of almost any biological process. miRs are

Glower

Troponin Elevation Beyond Coronary Arteries high-sensitivity assays, which can detect even small increases in troponin levels, resulted in an increase in the number of patients with elevated troponin concentrations. However, in this case there are more false-positive results. This makes it of paramount importance to set differential diagnosi

考古學(xué)

上坡

Macrophage Metalloprotease (MMP)-12 as a Cardiovascular Biomarker of CVD risk has focused the attention over the last years. Atherosclerosis (ATS) is one of the major causes of CVD. ATS is an inflammatory multifactorial disease, in which the complex interaction between immune cells and inflammatory mediators drives the growth of atherosclerotic lesions and their

萬(wàn)靈丹

Homocysteine as a Biomarker in Vascular Diseaser cofactors. Even a mild increase in the levels of Hcy is considered a risk factor for a number of diseases in humans, such as cardiovascular disease, stroke, neurodegenerative disorders like dementia and Alzheimer’s disease, birth defects, complicated pregnancies, and bone fractures. However, it ha

有抱負(fù)者

錯(cuò)誤

注射器